Aspirin Modifies Inflammatory Mediators and Metabolomic Profiles and Contributes to the Suppression of Obesity-Associated Breast Cancer Cell Growth
Open Access
- 30 June 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (13) , 4652
Abstract
Breast cancer is the most common cancer among women. Adiposity generally accompanies immune cell infiltration and cytokine secretion, which is ideal for tumor development. Aspirin is a chemopreventive agent against several types of cancer. The aim of this study was to investigate whether aspirin inhibits the growth of 4T1 breast cancer cells by inhibiting the inflammatory response and regulating the metabolomic profile of 3T3-L1 adipocytes. 3T3-L1 adipocyte-conditioned medium (Ad-CM) was used to mimic the obese adipose tissue microenvironment in 4T1 cells. The results revealed that aspirin inhibited macrophage chemoattractant protein (MCP-1), interleukin (IL-6), IL-1β, and plasminogen activator inhibitor (PAI-1) production in 3T3-L1 adipocytes stimulated by tumor necrosis factor-alpha (TNF-α) and lipopolysaccharide (LPS). In the obesity-associated model, Ad-CM significantly promoted 4T1 cell growth and migration, which were attenuated after aspirin treatment. The results of metabolic analyses using Ad-CM showed that amino acid metabolites and oxidative stress were increased in mature 3T3-L1 adipocytes compared to those in fibroblasts. Aspirin treatment modified metabolites involved in suppressing lipogenesis, oxidative stress, and neoplastic formation. In the relative fatty acid quantitation analysis of Ad-CM, aspirin diminished fatty acid contents of C16:1, C18:1, C18:2, C20:4, and C24:1. This study is the first to show that aspirin modifies the metabolomics and fatty acid composition of 3T3-L1 adipocytes and inhibits obesity-associated inflammation that contributes to obesity-related breast cancer cell growth and migration.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 106-2311-B-003-005-MY3)
This publication has 51 references indexed in Scilit:
- The Role of the Immune System in Obesity and Insulin ResistanceJournal of Obesity, 2013
- Adipose tissue immunity and cancerFrontiers in Physiology, 2013
- Current Evidence Linking Polyunsaturated Fatty Acids with Cancer Risk and ProgressionFrontiers in Oncology, 2013
- Mechanistic Targets and Phytochemical Strategies for Breaking the Obesity-Cancer LinkFrontiers in Oncology, 2013
- Aspirin and cancer risk: a quantitative review to 2011Annals of Oncology, 2012
- Cell culture metabolomics: applications and future directionsDrug Discovery Today, 2010
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementThe Lancet Oncology, 2009
- Endogenous 15‐deoxy‐Δ12,14‐prostaglandin J2 synthesized by adipocytes during maturation phase contributes to upregulation of fat storageFEBS Letters, 2006
- Metabolomics: The Greatest Omics of Them All?Analytical Chemistry, 2006
- Effect of the carcinogenic tyrosin metabolite, p-hydroxyphenyllactic acid, on ascorbic acid levels in mouse organs and bloodBulletin of Experimental Biology and Medicine, 1986